超短波治疗慢性肺源性心脏病患者的初步探讨

目的:探讨超短波对慢性肺心病CCP患者的临床应用价值。方法:急性发作期CCP患者87例分为超短波治疗组45例和对照组42例,治疗组在常规治疗的基础上给予超短波治疗,对照组行常规治疗。治疗前后分别测定两组患者血浆中血管内皮生长因子VEGF、内皮素(ET-1)含量,动脉血氧分压(PaO2)和平均肺动脉压(mPAP)水平。结果:与对照组比较治疗组治疗后PaO2显著升高(P<0.01),VEGF、ET-1、mPAP明显降低(P<0.01)。VEGF、ET-1与PaO2呈负相关(P<0.01)、与mPAP呈正相关(P<0.01)。结论:超短波可以通过降低肺动脉高压对CCP患者起治疗作用。

The Effect of Ultrashortwave Diathermy on the Patients with Chronic Pulmonary Heart Disease

Objective: To construction the clinical worth in patients with chronic cor pulmonale(CCP).Methods: 87 cases of CCP were divided into 2 groups,a treatment group with 45 cases treated with both ultrashortwave and conventional treatment and a control group with 42 cases treated with conventional treatment.The level of VEGF,ET-1 and PaO2,Mpap were tested before and after the treatment,respectively.Results: Compared with those of the control group,the PaO2 induced sputum was significantly increased after the treatment with ultrashortwave(P < 0.01),the VEGF,ET-1 and mPAP decreased in the treatment group more significantly than those in control group(P < 0.01).PaO2 was obviously negatively correlated to VEGF and ET-1,mPAP was obviously positive correlated to VEGF and ET-1.Conclusions: ultrashortwave diathermy is between for CCP patients by decreas the pulmonary hypertension.